# Veltassa (Veltassa Brand Values.md)
#
# IMPORTANT: the Veltassa Australian sponsor is in transition and these values
# MUST be confirmed against the current Veltassa Australian PI before use.
# TGA section-14 consents show the sponsor moving from Vifor Pharma Pty Ltd to
# Seqirus Pty Ltd (CSL group; CSL Vifor brand). The values below reflect the
# current Seqirus / CSL position as best determined on 2026-05-27.
# ABN 66 120 398 067 verified on ABN Lookup as SEQIRUS (AUSTRALIA) PTY LTD
# (registered business name CSL SEQIRUS). NOTE: the TGA consent names the sponsor
# as "Seqirus Pty Ltd"; confirm the exact legal entity (Seqirus Pty Ltd vs
# Seqirus (Australia) Pty Ltd) and its ABN with the client.
# Former sponsor for reference: Vifor Pharma Pty Ltd, Level 9, 140 William Street,
# Melbourne VIC 3000, phone +61 3 9686 0111.
# The Fallback mandatory disclaimer is NOT populated; it must be supplied verbatim
# by the medical / MLR team.
# Comment lines (starting with #) are ignored by the skill.

Brand: Veltassa
Sponsor name: Seqirus (Australia) Pty Ltd (CSL Vifor) [CONFIRM legal entity against current Veltassa PI]
Sponsor address: 63 Poplar Road, Parkville VIC 3052 [CONFIRM]
Sponsor phone: [CONFIRM customer/medical-info line]
Sponsor website: www.cslvifor.au
Sponsor ABN: 66 120 398 067 [CONFIRM: Seqirus (Australia) Pty Ltd; verify this is the Veltassa sponsor entity]
Fallback mandatory disclaimer: [REQUIRED FROM MEDICAL / MLR TEAM. Not populated from public sources. Supply the brand's MLR-approved minimum mandatory wording (for example the PBS listing / indication statement, the PI availability line, and the TGA adverse-event reporting statement). Keep verbatim.]